NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) announced today the full market release outside the U.S. of the Pronto ® Pulse CO-Oximeter ® with Next Generation SpHb ® Spot Check ...

Hailed as a “potential game-changing technology,” Dr. Andrew J. Schuman—adjunct assistant professor of pediatrics at Dartmouth Medical School, contributing editor for Contemporary Pediatrics, and a ...

The Pronto-7 is a small device intended for hassle-free and not-invasive total hemoglobin monitoring in conjunction with perfusion index, SpO2 and pulse rate. The flyweight Pronto-7 provides reading ...

Masimo (MASI) announced that PSS World Medical (PSSI) will distribute the new Pronto-7 - a palm-sized handheld device designed for quick and easy noninvasive spot-checking of total hemoglobin, SpO2, ...

26882 Towne Centre: 22nd medical office in OC for Kaiser Irvine-based patient monitor maker Masimo Corp. is planning to focus on “four key priorities” as 2013 unfolds. Chief Executive Joe Kiani said ...

Masimo Corp. has received Food and Drug Administration marketing approval for its Pronto-7. The handheld device offers, convenient, and non-invasive spot check testing of hemoglobin. The product can ...

Masimo Corporation ( MASI), a leader in non-invasive monitoring technology for patient care, and Easton Hospital of Pennsylvania recently revealed that Masimo is installing a patient monitoring set up ...

Masimo Corp.’s new distribution deal with Henry Schein Inc. holds growth prospects for the Irvine-based company’s Rainbow technology brand. Masimo announced earlier this month that Schein Medical, a ...

Masimo Corporation ( MASI), a leader in non-invasive monitoring technology for patient care, recently revealed that its Pronto-7 offering has been awarded a GOLD Stevie American Business Award. The ...